Jacot, W.; Maran-Gonzalez, A.; Massol, O.; Sorbs, C.; Mollevi, C.; Guiu, S.; Boissière-Michot, F.; Ramos, J.
Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other Biomarkers. Cancers 2021, 13, 6059.
https://doi.org/10.3390/cancers13236059
AMA Style
Jacot W, Maran-Gonzalez A, Massol O, Sorbs C, Mollevi C, Guiu S, Boissière-Michot F, Ramos J.
Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other Biomarkers. Cancers. 2021; 13(23):6059.
https://doi.org/10.3390/cancers13236059
Chicago/Turabian Style
Jacot, William, Aurélie Maran-Gonzalez, Océane Massol, Charlotte Sorbs, Caroline Mollevi, Séverine Guiu, Florence Boissière-Michot, and Jeanne Ramos.
2021. "Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other Biomarkers" Cancers 13, no. 23: 6059.
https://doi.org/10.3390/cancers13236059
APA Style
Jacot, W., Maran-Gonzalez, A., Massol, O., Sorbs, C., Mollevi, C., Guiu, S., Boissière-Michot, F., & Ramos, J.
(2021). Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other Biomarkers. Cancers, 13(23), 6059.
https://doi.org/10.3390/cancers13236059
